Confined to Hong Kong, Lung Fung lacks tonic for growth-hungry investors
The city’s leading pharmacy chain reported record revenue and profits in its latest fiscal year, lifting its shares Key Takeaways: Lung Fung reported its profit reached HK$269 million in its…
Regulatory caution dims Hong Kong SPAC outlook, while Chinese tastes drive out foreign brands
Hong Kong has completed just its third listing using a SPAC since the program's launch four years ago. Why has uptake been so anemic? And Hong Kong's popular Mannings health and beauty chain is pulling out of Mainland China after more than two decades in the market. Why is it calling it quits?
What 1.4 billion consumers? Mannings China exit extends foreign retail exodus
The withdrawal by Hong Kong’s largest health and beauty chain comes as parent DFI trims its money-losing assets, and follows a similar departure this year by peer Sa Sa International…
RELATED ARTICLES
-
China’s shrinking ‘Chicken King’ scurries towards Hong Kong IPO
- Local chick LXJ eyes big city lights with third Hong Kong IPO bid
- ‘Plum king’ sweetens fourth IPO bid with new products, price cuts
- JD.com pours $4.5 billion into Hong Kong. But when will it recoup that money?
-
Struggling Shimao looks on as creditors move in on its trophy Hong Kong hotel
0813.HK
- JD Health’s AI push sets up a battle of the digital doctors
